Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good morning Rudy, can you please tell me what the 150 year mark is for? tia
DITTO!!!
Thanks food. I'm truly hoping for the best...for all of us.
Prepare for a possible R/S...accumulate, accumulate, accumulate. Depending on your circumstances, it may help.
Just don't forget to buy shares for Uncle Sam ;)
Two thirds for you, one for him.
From Onlyinvestor's IR email response:
No Jim, I'm not a pumper. I wouldn't like that kind of job. In fact, I'm retired and not interested in ever working again.
Also, if you remember, I've been the one screaming about the 1 billion shares and no insider buying.
I will however, post that I am "cautiously" optimistic as I've done many times before.
So, I don't think a pumper would admit to being "cautious", do you?
More than likely, those shares belong to individuals that purchased them via the institutions.
Thank you 1234
I thought it was a Janssen rep. Does anyone remember? Rudy??? tia
Who was the J&J head of cancer unit that attended our bio presentation? tia
If you'll just stop with your negative speculation and take the time to read PMCB's PR's over the last 12 months you'll come to realize just how much this company and it's technology has advanced. Soon, PharmaCyte and it's amazing consortium of world renowned doctors and scientists will once and for all prove the CiaB therapy revelation.
Seriously Bear, you really need to read over the PR's. Don't speculate, you're only cheating yourself out of a wonderful opportunity to be a part of this pivotal moment in PC.
Oh darling, you need to be more patient. IND certainly coming.
btw, if you'll just dig a little deeper, you'll learn that under FDA CiaB is device...didn't mean to bust your bubble.
Now, you have a great Sunday. :) :) :)
The CAPR 5yr chart is certainly mesmerizing!!!...
If only, right? :) :) :)
Aduro recently failed at what was supposed to be a successful therapy trial for PC. J&J dumps them...think about it.
Janssen at PharmaCyte with eyes and ears wide open...think about it.
Janssen/J&J is aware of PharmaCyte's proven and much better therapy.
IND + Janssen partnership/funding = ka ka ka BOOM!!!!!!
JANSSEN!!!, JANSSEN!!!, JANSSEN!!!
ACCUMULATE!!!, ACCUMULATE!!!, ACCUMULATE!!!
Remember, Mr. Waggoner said he's not willing to serve up any insight as to when to expect the submission.
It sure keeps the suspense high while the speculation runs amuck. :)
We've done our part, we're just waiting for everyone else to do theirs...then, the IND can happen. :) :) :)
Frustrating?, sure it is, but it's reasonable.
A fast track straight to pivotal trial will certainly happen just as soon as a few more boxes are checked.
IND is closely upon you. :)
You can take that to the bank! :) :) :)
PMCB current pps and position:
"...a large discount to potential value – with potential value rooted in what we see as an inflection point for Pharmacyte. Unfortunately, we don’t know when this inflection point will come. Management has sort of gone out of its way to make sure we have no idea, which is a bit frustrating, but in some ways justifiable (think NDA's), but the thesis still stands – when it hits, we’re going to see some immediate upside in Pharmacyte’s market capitalization.
Technically, not only has it been improved, but there is still plenty of time for changes. It's all allowed within the 12 month time period.
Yeah, the charts posted here always look good...(yawn)... but the fundamentals are nothing short of incredibly amazing!!! :) :) :)
Well, in doing my DD I learned just a slight bit different in my response today from PharmaCyte than what I read in the email that posted earlier.
All in all, things for me still continue to be positive and moving forward.
xxxx xxxxxxx;
Thank you for your email and for your interest in PharmaCyte Biotech. Yes, this is a reply from PharmaCyte’s investment relations. Don’t confuse both cancer and diabetes however. These are two very different programs, and any funding expected for the company's pancreatic cancer clinical trial is not funding that will also go towards the company’s diabetes program. We thought we made that clear in the response; however, there does seem to be some confusion.
Thank you again for your email and for your interest in PharmaCyte.
Investor Relations
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
O 917.595.2850 | F 917.595.2851 | M 917.595.2856
Go PharmaCyte!
Janssen! Janssen! Janssen!
I would have to agree with you. In fact, and I'm not calling Pete a liar either, but this morning I cut and pasted the body of the email in my own email to IR and asked them to confirm it. I'm still waiting for a response.
I don't feel a slight bit guilty for doing it because it's all a part of doing my DD.
And I will give my hubby the money to build our cabin on the lake. ;)
Well, I've purchased 100,000 shares for me and 50,000 shares for uncle Sam. Now, I don't want to be cut short on them because of a reverse split so I hope it shoots above one dollar quickly.
Thank you very much Rudy. I hope you're right...I hope you're right.
I guess a more germane way to ask my question is, if you were about to own the holy Grail of cell encapsulation wouldn't you be buying as many shares as possible?
Concordia, Do you think Mr. Waggoner should have purchased shares at this point, or do you think he's completely satisfied with his awarded shares insread?
That's OK, thank you Musky. :) :) :)
rudygerner, could you please share with me why you think there is no insider buying? tia
Why does no one ever talk about no insider buying, or did I miss that conversation?
Does that not concern anyone?
Thank you Musky for your reply. However, you never gave your opinion on no insider buying.
1234jklm and OldMusky, I could definitely lean towards this being best case scenario. In fact, 1234jklm, your explanation is quite clear, and assuming you are correct, and everything positive posted recently about PMCB's success, then how do you explain no insider buying?
It would be great to hear EVERYONE chime in, but I know that won't happen.
Which, by the way, I find very odd.
I'm not taking any sides here, but I do think the possibility certainly exists for strong trial outcomes to drive an uplist before a partnership. This means that there is potentially a chance for a reverse split. Of course, depending on your circumstances, a reverse split can be good or bad. jmo
Reading back one year (far enough) at chart postings here I have yet to find one yielding any major significance. However, PharmaCyte's extraordinary fundamentals are in support of a very long success story.
Good post Best